Related Experiment Video
Updated: Mar 22, 2026
07:42
Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
Published on: April 26, 2012
18.6K
Usability and Acceptability of a Web-Based Program for Chemotherapy-Induced Peripheral Neuropathy
Cindy Tofthagen1, Kevin E Kip, Denise Passmore
1Author Affiliations: University of South Florida, Tampa (Drs Tofthagen, Kip and Passmore and Mr Loy); and Dana-Farber Cancer Institute and Harvard Medical School in Boston, Massachusetts (Dr Berry).
Computers, Informatics, Nursing : CIN
|April 27, 2016
Summary
A new web-based program, COPE-CIPN, shows promise for helping patients manage chemotherapy-induced peripheral neuropathy. It demonstrated good usability and acceptability, with a moderate effect on reducing daily life interference from symptoms.
Area of Science:
- Oncology
- Neurology
- Digital Health
Background:
- Chemotherapy-induced neuropathy (CIPN) is a significant adverse effect of cancer treatment.
- Existing self-management resources for CIPN are limited in accessibility and patient-centered design.
Purpose of the Study:
- To evaluate the usability and acceptability of a novel web-based intervention, the Creativity, Optimism, Planning, and Expert Information for Chemotherapy-Induced Peripheral Neuropathy (COPE-CIPN) program.
- To estimate the effect size of the COPE-CIPN on managing CIPN symptoms and their impact on daily activities.
Main Methods:
- A cohort of 14 participants used the COPE-CIPN program.
- Usability was assessed using the Post-Study System Usability Questionnaire.
- Acceptability was measured using the Acceptability e-Scale.
- Changes in CIPN symptom interference were tracked using the Chemotherapy Induced Peripheral Neuropathy Assessment Tool.
Main Results:
- The COPE-CIPN program achieved high usability (mean score 1.98) and acceptability (mean score 4.40).
- Participants found the interface easy to navigate and the information provided helpful.
- A moderate effect size (d = 0.39) was observed, with a decrease in the mean interference of CIPN symptoms with activities from 53.71 to 39.29 over 3-4 months.
Conclusions:
- The COPE-CIPN web-based intervention is usable and acceptable for patients experiencing chemotherapy-induced neuropathy.
- This digital tool shows potential as a supportive intervention for self-managing CIPN and mitigating its impact on quality of life.
Related Concept Videos
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
727
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
727
01:26Peripheral Artery Disease IV: Nursing Management
578
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
578
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
786
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
786
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
1.0K
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
1.0K
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
926
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
926
01:27Peripheral Artery Disease III: Interprofessional Care
539
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
539